RhumbLine Advisers’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.75M | Buy |
136,588
+4,123
| +3% | +$52.5K | ﹤0.01% | 1926 |
|
|
2025
Q4 | $1.19M | Sell |
132,465
-27,014
| -17% | -$372K | ﹤0.01% | 2139 |
|
|
2025
Q3 | $2.75M | Sell |
159,479
-4,767
| -3% | -$58.7K | ﹤0.01% | 1735 |
|
|
2025
Q2 | $1.54M | Buy |
164,246
+7,408
| +5% | +$60.8K | ﹤0.01% | 2024 |
|
|
2025
Q1 | $1.12M | Sell |
156,838
-9,410
| -6% | -$95K | ﹤0.01% | 2121 |
|
|
2024
Q4 | $1.94M | Buy |
166,248
+3,499
| +2% | +$54.6K | ﹤0.01% | 1894 |
|
|
2024
Q3 | $3.34M | Sell |
162,749
-12,586
| -7% | -$290K | ﹤0.01% | 1625 |
|
|
2024
Q2 | $3.92M | Buy |
175,335
+8,797
| +5% | +$209K | ﹤0.01% | 1522 |
|
|
2024
Q1 | $4.58M | Buy |
166,538
+3,180
| +2% | +$88.3K | ﹤0.01% | 1464 |
|
|
2023
Q4 | $4.98M | Sell |
163,358
-627
| -0.4% | -$18K | 0.01% | 1411 |
|
|
2023
Q3 | $5.19M | Buy |
163,985
+1,578
| +1% | +$61.2K | 0.01% | 1316 |
|
|
2023
Q2 | $6.62M | Buy |
162,407
+14,596
| +10% | +$592K | 0.01% | 1217 |
|
|
2023
Q1 | $5.51M | Buy |
147,811
+3,533
| +2% | +$139K | 0.01% | 1257 |
|
|
2022
Q4 | $5.03M | Buy |
144,278
+16,448
| +13% | +$782K | 0.01% | 1272 |
|
|
2022
Q3 | $7.15M | Buy |
127,830
+8,270
| +7% | +$513K | 0.01% | 1064 |
|
|
2022
Q2 | $6.19M | Buy |
119,560
+21,313
| +22% | +$1.08M | 0.01% | 1140 |
|
|
2022
Q1 | $7.14M | Buy |
98,247
+2,620
| +3% | +$222K | 0.01% | 1111 |
|
|
2021
Q4 | $11.3M | Sell |
95,627
-3,155
| -3% | -$395K | 0.01% | 922 |
|
|
2021
Q3 | $13.3M | Buy |
98,782
+315
| +0.3% | +$47.7K | 0.02% | 802 |
|
|
2021
Q2 | $15.9M | Buy |
98,467
+1,446
| +1% | +$113K | 0.02% | 735 |
|
|
2021
Q1 | $7.79M | Sell |
97,021
-5,015
| -5% | -$337K | 0.01% | 1147 |
|
|
2020
Q4 | $5.55M | Buy |
102,036
+4,109
| +4% | +$149K | 0.01% | 1300 |
|
|
2020
Q3 | $1.95M | Buy |
97,927
+6,188
| +7% | +$129K | ﹤0.01% | 1695 |
|
|
2020
Q2 | $1.93M | Buy |
91,739
+16,107
| +21% | +$274K | ﹤0.01% | 1751 |
|
|
2020
Q1 | $925K | Buy |
75,632
+6,358
| +9% | +$85.7K | ﹤0.01% | 1912 |
|
|
2019
Q4 | $1.02M | Buy |
69,274
+3,229
| +5% | +$44.9K | ﹤0.01% | 2078 |
|
|
2019
Q3 | $882K | Buy |
66,045
+5
| +0% | +$80 | ﹤0.01% | 2093 |
|
|
2019
Q2 | $1.08M | Buy |
66,040
+12,193
| +23% | +$192K | ﹤0.01% | 2034 |
|
|
2019
Q1 | $920K | Buy |
53,847
+5,716
| +12% | +$85.2K | ﹤0.01% | 2077 |
|
|
2018
Q4 | $657K | Buy |
48,131
+18,050
| +60% | +$336K | ﹤0.01% | 2175 |
|
|
2018
Q3 | $861K | Sell |
30,081
-2,025
| -6% | -$58.9K | ﹤0.01% | 2064 |
|
|
2018
Q2 | $878K | Buy |
32,106
+15,201
| +90% | +$368K | ﹤0.01% | 2062 |
|
|
2018
Q1 | $357K | Buy |
16,905
+1,155
| +7% | +$28.4K | ﹤0.01% | 2360 |
|
|
2017
Q4 | $303K | Sell |
15,750
-1,706
| -10% | -$39.4K | ﹤0.01% | 2464 |
|
|
2017
Q3 | $434K | Buy |
17,456
+290
| +2% | +$5.46K | ﹤0.01% | 2379 |
|
|
2017
Q2 | $275K | Buy |
+17,166
| New | +$240K | ﹤0.01% | 2601 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
